xpro1595 webinar on expanded phase 1b data in patients with alzheimer’s disease
Published 3 years ago • 1.2K plays • Length 59:30Download video MP4
Download video MP3
Similar videos
-
54:42
webinar on xpro1595 phase ib interim data of neuroinflammation in patients with alzheimer's disease
-
1:44
how xpro1595 ("xpro") is unique to other tnf inhibitors
-
51:31
webinar on results of xpro in ad showing improvements in white matter pathology and decrease in ptau
-
2:35
inmune bio phase 2 clinical trial of xpro in alzheimer's disease
-
2:04
xpro1595
-
3:41
xpro1595 patient experience
-
2:12
the inmune bio approach to alzheimer's disease
-
2:36
alzheimer's disease
-
43:32
"advancing treatment to repair our aging innate immune system to fight alzheimer’s" inmune bio(inmb)
-
3:04
viewing alzheimer's as an immunological disease with symptoms of neurodegeneration
-
57:01
bench to bedside a pre ctad webinar highlighting an alternative approach for alzheimer’s disease
-
2:05
targeting neuroinflammation in alzheimer's disease
-
59:02
webinar on inkmune, a natural killer therapy for a phase i/ii trial in metastatic prostate cancer
-
11:13
inside inmune bio | episode 2 - tnf "the master cytokine"
-
2:40
neuroinflammation & alzheimer's disease
-
2:46
introduction to inmune bio
-
46:10
"improving white matter integrity in alzheimer's disease" inmune bio (nasdaq:inmb) ceo & cfo 9-3-21
-
9:04
positive results from an alzheimer's clinical trial